Sofia, Bulgaria, February 7, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for January 2022 the Company recorded an increase in sales of 51% compared to the same month of the previous year, incl. normalization of domestic sales with an increase of 254% due to the low base and 35% decrease in export sales.